Filing Overview
Mohawk Group Holdings, Inc. (now Aterian, Inc.; Nasdaq: MWK) filed a Form 8-K dated April 29, 2020 under Item 8.01. The filing addresses COVID-19-related delays to its 2020 annual meeting proxy statement and Part III information from its 2019 Form 10-K. It also provides an expected filing date for the quarterly report covering the quarter ended March 31, 2020.
Financial Metrics and Liquidity
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Management stated that it was seeking to preserve liquidity and capital resources, potentially including negotiating delayed payments to certain vendors. The filing cautioned that the Company might be unable to comply with existing credit facility terms, obtain waivers, or secure additional financing. Any successful financing could be expensive or dilutive.
Material Changes and Filing Delays
- The Company relied on the SEC’s March 25, 2020 COVID-19 relief order permitting eligible reporting delays of up to 45 days.
- The definitive proxy statement for the 2020 annual meeting, including the Part III information omitted from the 2019 Form 10-K, was expected on or about May 15, 2020 and no later than June 13, 2020.
- The Company expected to file its Form 10-Q for the quarter ended March 31, 2020 on or about May 11, 2020.
- COVID-19-related operational disruptions, restricted office access, and diverted management resources delayed preparation of the proxy statement.
Outlook, Risks, and Unusual Items
- The Company reported disruptions affecting employees, suppliers, logistics providers, warehouses, online marketplaces, and other business partners.
- Potential impacts included delays or inability to launch products, replenish inventory, receive or ship inventory, and sell products to customers.
- Most employees were working remotely, creating operational and product-quality challenges.
- The Company stated that demand for its largely non-essential products could decline materially and that forecasting demand during the pandemic was difficult.
- Reliance on third-party manufacturing, logistics, warehousing, and online marketplaces limited the Company’s ability to control continuity plans.
- Additional cited risks included supply-chain disruption, tariffs, inventory management, regulatory compliance, product liability or recalls, seasonal revenue variation, acquisitions, cash flows, and revenue growth.
Investor Verification Items
- Verify whether the proxy statement and Part III information were filed by the stated deadlines.
- Verify the actual filing date and financial results in the March 31, 2020 Form 10-Q.
- Review liquidity, debt covenant compliance, vendor payment deferrals, and any subsequent financing or waiver arrangements.
- Assess COVID-19 effects on inventory, fulfillment, product demand, suppliers, marketplaces, and cash flow.
- Review later filings for changes to the Company’s name, trading symbol, risk factors, and going-concern or financing disclosures.